Insurers also filed a class action against the company, claiming it tricked them into covering Neurontin
prescriptions for unapproved uses, such as the treatment of bipolar disorder.
Pfizer won federal Food and Drug Administration (FDA) approval for doctors to use Neurontin
to treat conditions such as seizures and nerve-related pain.
, used to treat epilepsy and long-lasting pain caused by damage to the nerves, can also result in drowsiness and lack of coordination.
Seroquel and Neurontin
could both cause sleepiness if taken accidentally.
2 June 2011 - Israeli Teva Pharmaceutical Industries Ltd (TLV: TEVA, NASDAQ: TEVA) said yesterday that the patent litigation with US Pfizer Inc (NYSE: PFE) related to generic versions of Pfizer's anticonvulsant Neurontin
(gabapentin) capsules and tablets sold by Teva and its subsidiary IVAX Pharmaceuticals has been dismissed by the US District Court for the District of New Jersey pursuant to a settlement between the parties.
Matrix Laboratories Limited's Gabapentin Capsules USP, 100 mg, 300 mg and 400 mg is the generic version of Pfizer's Neurontin
Pfizer faces more than 1,000 lawsuits accusing it of illegally promoting Neurontin
for unapproved uses and helping to cause some users' suicides.
In the earlier case, Pfizer s Warner Lambert subsidiary had been accused of marketing Neurontin
for unapproved uses.
The lawyer, Andrew Finkelstein, said he filed the petition last May when he had amassed reports of 100 suicides and several hundred attempts in patients taking Neurontin
for unapproved uses such as back pain and psychiatric conditions such as depression.
Instead, he was encouraged to promote the drug Neurontin
for off-label uses, despite a dearth of legitimate studies showing its efficacy.
has been approved by the FDA to be used as adjunctive therapy (in conjunction with other medications) for the treatment of epilepsy only; 80 percent of Neurontin
prescriptions are for unapproved uses.
NEW YORK -- Pfizer Inc said today that an appeals court has overturned a lower court ruling that several generic manufacturers did not infringe the company's patent for stabilized formulations of gabapentin, the active ingredient in Neurontin
Specialty pharmaceutical company Hi-Tech Pharmacal Co Inc (Nasdaq:HITK), a specialty pharmaceuticals company, announced on Tuesday that the US Food and Drug Administration, (FDA) granted final approval for its Abbreviated New Drug Application, (ANDA) for gabapentin oral solution 250mg/5mL, the generic for Pfizer's Neurontin
racketeering law in the marketing of its epilepsy drug Neurontin
and should pay $142.
The women were randomly selected to receive daily doses of 300 mg or 900 mg of Neurontin
(generic name: gabapentin) or a dummy drug.